1. Home
  2. KRMD vs ADAG Comparison

KRMD vs ADAG Comparison

Compare KRMD & ADAG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo KORU Medical Systems Inc. (DE)

KRMD

KORU Medical Systems Inc. (DE)

HOLD

Current Price

$4.22

Market Cap

195.7M

Sector

Health Care

ML Signal

HOLD

Logo Adagene Inc.

ADAG

Adagene Inc.

HOLD

Current Price

$3.78

Market Cap

146.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KRMD
ADAG
Founded
1980
2011
Country
United States
China
Employees
73
N/A
Industry
Medical/Dental Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
195.7M
146.3M
IPO Year
2019
2020

Fundamental Metrics

Financial Performance
Metric
KRMD
ADAG
Price
$4.22
$3.78
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
4
Target Price
$6.50
$8.00
AVG Volume (30 Days)
137.3K
233.4K
Earning Date
03-12-2026
03-24-2026
Dividend Yield
N/A
N/A
EPS Growth
53.85
N/A
EPS
N/A
N/A
Revenue
$41,127,366.00
N/A
Revenue This Year
$20.32
$3,688.61
Revenue Next Year
$17.38
$17.39
P/E Ratio
N/A
N/A
Revenue Growth
22.23
N/A
52 Week Low
$1.87
$1.33
52 Week High
$6.61
$4.58

Technical Indicators

Market Signals
Indicator
KRMD
ADAG
Relative Strength Index (RSI) 36.30 53.63
Support Level $4.08 $1.69
Resistance Level $4.34 $4.58
Average True Range (ATR) 0.20 0.52
MACD 0.02 -0.01
Stochastic Oscillator 23.36 47.09

Price Performance

Historical Comparison
KRMD
ADAG

About KRMD KORU Medical Systems Inc. (DE)

KORU Medical Systems Inc develops, manufactures, and commercializes large volume subcutaneous infusion solutions for the subcutaneous drug delivery market. Its product portfolio focuses on mechanical infusion devices, including the FREEDOM60 and FreedomEdge syringe drivers, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing. The company operates as one segment. Its revenue streams are: Domestic Core, International Core and Pharma services and clinical trials. The majority of the company's revenue is derived from the Domestic Core business, which consists of sales of its syringe drivers, tubing and needles. Geographically, its revenues are predominantly derived from the United States.

About ADAG Adagene Inc.

Adagene Inc is a platform-driven, clinical-stage biopharmaceutical company engaged in transforming the discovery and development of novel antibody-based cancer immunotherapies. It is principally engaged in research, development, and production of monoclonal antibody drugs for cancers. The company's platform is designed to generate therapeutic antibody candidates with functional epitopes and species cross-reactivity, as highlighted by the company's immunotherapy pipeline.

Share on Social Networks: